Rchr
J-GLOBAL ID:201901014013148348   Update date: Sep. 01, 2020

Keigo Okada

オカダ ケイゴ | Keigo Okada
Affiliation and department:
Job title: Assistant Professor
Research theme for competitive and other funds  (1):
  • FLT3-ITD陽性AMLに対するRSKを標的とした新規治療法の開発
Papers (9):
more...
Lectures and oral presentations  (15):
  • FLT3-ITD Enhances Proliferation and Survival of AML Cells through Activation of RSK1 to Upregulate the mTORC1/eIF4F Pathway Cooperatively with PIM or PI3K and to Inhibit Bad and Bim
    (60th ASH Annual Meeting and Exposition 2019)
  • Deubiquitinase Inhibitor WP1130 Blocks FLT3-ITD to Induce Apoptosis in Leukemic Cells
    (59th ASH Annual Meeting & Exposition 2017)
  • Deubiquitinase inhibitor WP1130 blocks JAK2-V617F to induce apoptosis in leukemic cells
    (The 79th Annual Meeting of the Japanese Society of Hematology 2017)
  • Autophagy and Bcl-2 family members protect JAK2-V617F-expressing leukemic cells from ruxolitinib
    (第79回日本血液学会学術集会 2017)
  • Modulation of the mTORC1 pathway by ubiquitin-proteasome system via REDD1 in AML with FLT3-ITD
    (The 79th Annual Meeting of the Japanese Society of Hematology 2017)
more...
Professional career (1):
  • 医学博士
Work history (3):
  • 2019/11/01 - 現在 Tokyo Medical and Dental University Medical Hospital Hospital Departments Department of Internal Medicine Hematology Assistant Professor
  • 2019/09/01 - 2019/10/31 Tokyo Medical and Dental University Medical Hospital Hospital Departments Department of Internal Medicine Hematology Assistant Professor
  • 2014/04/01 - 2018/03/31 Tokyo Medical and Dental University Graduate School of Medical and Dental Sciences Medical and Dental Sciences Advanced Therapeutic Sciences Hematology Graduate Student
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page